Financial News
Therapeutic Solutions International Recruits Internationally Renowned Stem Cell Clinician and San Diego Top Doctor to Scientific Advisory Board
Appointment of Dr. Navneet Boddu to Expand Patient Access to Stem Cells in FDA Compliant Manner
Therapeutic Solutions International, Inc. (TSOI), announced today the appointment of internationally renowned stem cell therapist Dr. Navneet Boddu to the Company’s Scientific Advisory Board. Dr. Boddu joins eminent luminaries in the regenerative medicine/immunotherapy space such as Dr. Santosh Kesari, Dr. Francesco Marincola1, Dr. Donald Banerji2, and Dr. Boris Minev3.
Dr. Boddu previously obtained for Therapeutic Solutions International Emergency IND approval to treat a patient with COVID-19 using JadiCells. Therapeutic Solutions International plans to expand ongoing patient access to JadiCells as it advances in their development.
“I have known Dr. Boddu and his pioneering work in the area of regenerative medicine for some time now and it is an honor to finally work with him in a formal manner,” said Dr. Thomas Ichim, Board Member of Therapeutic Solutions International. “Dr. Boddu represents a very rare combination of excellent scientist, doctor, and businessperson. He has pioneered numerous medical procedures and is well known and respected in the stem cell community.”
Dr. Boddu is affiliated with Scripps Memorial Medical Center, Encinitas; Tri City Medical Center; North Coast Surgery Center; and Carlsbad Surgery Center. He is board certified in Pain Medicine, Anesthesiology and Echocardiography. Dr. Boddu was chosen as Top Doctor of San Diego in 2022, 2021, and 2017.
“As an organization, we are rapidly advancing on many fronts of regenerative medicine including the treatment of aortic aneurysms (VasoSome Vascular Inc)4, chronic traumatic encephalopathy (CTE Biologics Inc)5, chronic obstructive pulmonary disease (Breath Biologics Inc)6, mental illness (Campbell Neurosciences Inc)7, and Oncology (Res Nova Bio Inc)8. Working with a regenerative medicine pioneer who has numerous experiences with the FDA will assist in accelerating progress of these programs through regulatory agencies,” said Timothy Dixon, President, and CEO of Therapeutic Solutions International. “I met Dr. Boddu during the COVID19 crisis during which his leadership in bringing stem cells to patients had saved numerous lives. We are truly excited to join forces with a true “medical hero.”
About Therapeutic Solutions International, Inc.
Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. The Company's corporate website is www.therapeuticsolutionsint.com.
1 Therapeutic Solutions International, Inc. Appoints Francesco Marincola to Scientific Advisory Board -July 23, 2018 at 09:00 am EDT | MarketScreener
2 Therapeutic Solutions International Recruits Dr. Donald Banerji to Scientific Advisory Board | BioSpace
3 Therapeutic Solutions International Appoints Internationally Renowned Tumor Immunologist Dr. Boris Minev to its Scientific Advisory Board | BioSpace
4 Therapeutic Solutions Launches VasoSome Vascular Inc. to Commercialize Aortic Aneurysm Treatment - Endovascular Today (evtoday.com)
5 Therapeutic Solutions International Launches Subsidiary Company to Commercialize Clinical Data and IND for Treatment of Chronic Traumatic Encephalopathy (CTE) with JadiCell Universal Adult Stem Cells (yahoo.com)
6 Spinoff Breathe Biologics to Lead TSOI's Stem Cell Therapy Research | COPD News Today
7 Therapeutic Solutions International Announces Titan of Industry Dr. Peter Farrell Joins Advisory Board of its Suicide Prevention Spin-Off Campbell Neurosciences (prnewswire.com)
8 Therapeutic Solutions International Spin-Off Res Nova Bio Leverages FDA Cleared Tumor Blood Vessel Targeting Technology to Intravenously Deliver Cancer Killing Viruses | Business Wire
View source version on businesswire.com: https://www.businesswire.com/news/home/20230918468422/en/
Contacts
Timothy G. Dixon
ir@tsoimail.com
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.